Royalty Pharma Q4 Adj. EPS $1.47 Beats $1.33 Estimate, Sales $622.000M Miss $795.915M Estimate

Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.47 per share which beat the analyst consensus estimate of $1.33 by 10.86 percent. This is a 26.72 percent increase over earnings of $1.16 per share from the same period last year. The company reported quarterly sales of $622.000 million which missed the analyst consensus estimate of $795.915 million by 21.85 percent. This is a 4.71 percent increase over sales of $594.000 million the same period last year.